Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
29M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
432K
-
Shares change
-
-497K
-
Total reported value, excl. options
-
$495K
-
Value change
-
-$755K
-
Number of buys
-
4
-
Number of sells
-
-7
-
Price
-
$1.14
Significant Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q2 2024
18 filings reported holding ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share as of Q2 2024.
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 432K shares
of 29M outstanding shares and own 1.49% of the company stock.
Largest 10 shareholders include Apollon Financial, LLC (225K shares), New Leaf Venture Partners, L.L.C. (97.1K shares), RENAISSANCE TECHNOLOGIES LLC (64K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (38.5K shares), MORGAN STANLEY (5.48K shares), WELLS FARGO & COMPANY/MN (1.29K shares), Activest Wealth Management (133 shares), Kelly Financial Services LLC (120 shares), Tower Research Capital LLC (TRC) (100 shares), and Planning Capital Management Corp (40 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.